Jade Biosciences Inc. (JBIO)
Market Closed
17 Jul, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
20. 86
+0.38
+1.8555%
$
683.51M Market Cap
- P/E Ratio
2.4% Div Yield
659,500 Volume
- Eps
$ 20.48
Previous Close 
Want to track JBIO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Jade Biosciences Inc. (JBIO) Statistics
Valuation metrics
Market Cap 683.51M
Enterprise value 626.17M
Trailing P/E (ttm) -7.14
Forward P/E -
PEG ratio -0.02
Price/Sales (ttm) -
Price/Book (mrq) 4.07
Enterprise Value/Revenue -
Enterprise Value/EBITDA -4.84
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 649.73K
Average volume (90 days) 811.65K
Price summary
52-Week low 6.67
52-Week high 28
Beta -
50-Day moving average 19.13
200-Day moving average 17.62
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 28 Apr 2025
Ex-Dividend Date 29 Apr 2025
Last split factor 1:35
Last split Date 29 Apr 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.41%
Return on equity -0.51%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.24
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 5.39
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 14.29%
Book value per share (mrq) 5.13
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
